Results 151 to 160 of about 40,562 (182)
Methylphenidate in Tardive Dyskinesia [PDF]
American Journal of Psychiatry, 1973 Methylphenidate, an amphetamine-like central nervous system (CNS) stimulant used successfully in reversing acute neuroleptic-induced neurological symptoms, was given in a placebo-controlled study to 17 patients with tardive dyskinesia. On global ratings three subjects were improved, six showed an increase in symptoms, and eight showed no changes.
William E. Fann +2 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
A Profile of Methylphenidate Exposures
Journal of Toxicology: Clinical Toxicology, 2000Methylphenidate is prescribed commonly for children with attention deficit hyperactivity disorder. An estimated 2.8% of US youths aged 5 to 18 years use it for the management of this disorder. Despite the widespread use of methylphenidate, the demographics and outcome of intentional and unintentional exposures to methylphenidate have not been described.
Rebecca Foley +3 more
openaire +3 more sources
Sensitization of mice to methylphenidate
Psychopharmacology, 1982Mice that received five daily injection of methylphenidate HCl, 10-75 mg/kg, showed an increased running response to methylphenidate, cocaine, and amphetamine. Sensitization to methylphenidate persisted for at least 50 days. Repeated IP injections of methylphenidate into mice with unilateral striatal lesions increased ipsilateral turning in response to
Shuster, L +3 more
openaire +3 more sources
Treatment of Apathy With Methylphenidate
The Journal of Neuropsychiatry and Clinical Neurosciences, 2007Apathy is a common condition that transcends psychiatric diagnoses. Its treatment is not well studied. The authors present four cases of apathy treated with a regimen of methylphenidate. Significant improvement in apathy and its sub-domains (motivation, novelty, and persistence) were noted.
Prasad R. Padala +3 more
openaire +3 more sources
2015
This chapter reviews methylphenidate misuse, abuse, dependence, diversion, and malingering associated with its use as a prescription medication for attention-deficit/hyperactivity disorder and the nonmedical use linked to its stimulant effects. Methylphenidate-induced regional elevations in brain dopamine appear to be integral to both efficacy in ...
openaire +3 more sources
This chapter reviews methylphenidate misuse, abuse, dependence, diversion, and malingering associated with its use as a prescription medication for attention-deficit/hyperactivity disorder and the nonmedical use linked to its stimulant effects. Methylphenidate-induced regional elevations in brain dopamine appear to be integral to both efficacy in ...
openaire +3 more sources
The Use of Methylphenidate in Michigan
Archives of Pediatrics & Adolescent Medicine, 1995To describe the epidemiologic findings associated with the use of methylphenidate hydrochloride among children aged 0 to 19 years in Michigan.A population-based data set of all prescriptions filed with the Michigan Triplicate Prescription Program during February and March 1992 was analyzed, maintaining complete anonymity.State of Michigan.All patients ...
James R. Jetton +3 more
openaire +3 more sources
Methylphenidate (OROS??Formulation)
CNS Drugs, 2001Methylphenidate is a CNS stimulant that is thought to block the reuptake of dopamine and noradrenaline (norepinephrine) into the presynaptic neuron. A sustained release (OROS formulation of the drug has been developed for use in children with attention deficit/hyperactivity disorder (ADHD).
Blair Jarvis +2 more
openaire +3 more sources
AMPHETAMINE AND METHYLPHENIDATE PSYCHOSIS
Biochemical Pharmacology, 1973Publisher Summary This chapter discusses the amphetamine and methylphenidate psychosis. A total of 17 actively ill schizophrenic patients, who were in good health without cardiovascular or other physical illness were administered active drug by a single injection, preceded and followed by placebo injections every 5 min.
David S. Janowsky +3 more
openaire +2 more sources
Methylphenidate for Giggle Incontinence
Journal of Urology, 2009Giggle incontinence or enuresis risoria is a socially embarrassing problem characterized by involuntary and complete bladder emptying in response to laughter. To our knowledge the cause of giggle incontinence is unknown, although a functional relationship to cataplexy was suggested.
Stephen A. Zderic +4 more
openaire +3 more sources
Journal of the American Medical Association, 1959
To the Editor:— I read with interest the article, "Double-Blind Evaluation of Methylphenidate (Ritalin) Hydrochloride" by Darvill, inThe Journal, April 11, page 1739, because I am conducting a study of this drug in outpatient psychiatric patients, as an adjuvant to psychotherapy.
openaire +2 more sources
To the Editor:— I read with interest the article, "Double-Blind Evaluation of Methylphenidate (Ritalin) Hydrochloride" by Darvill, inThe Journal, April 11, page 1739, because I am conducting a study of this drug in outpatient psychiatric patients, as an adjuvant to psychotherapy.
openaire +2 more sources